Abstract: A display system for sensing a finger of a user applied to the display system includes a display panel; a sensor for sensing the finger; a sensing light source configured to emit a first light having a first wavelength W1; and a reflective polarizer disposed between the display panel and the sensor. For a substantially normally incident light, an optical transmittance of the reflective polarizer versus wavelength for a first polarization state has a band edge such that for a first wavelength range extending from a smaller wavelength L1 to a greater wavelength L2 and including W1, where 30 nm?L2?L1?50 nm and L1 is greater than and within about 20 nm of a wavelength L3 corresponding to an optical transmittance of about 50% along the band edge, the optical transmittance has an average of greater than about 75%.

Abstract: The present invention relates to methods and compositions for determination of and uses of specific methylation patterns indicative of adenoma and carcinoma. In particular, the invention relates to analysis of defined CpG loci that are coordinately methylated in DNAs from cancer and adenoma samples, methods for identifying coordinately methylated loci, and methods of using analysis of coordinately methylated loci in one or more marker regions in the design of assays for adenoma and cancer.

Abstract: The present disclosure relates to detecting one or more types of gynecological cancer in a biological sample from a subject. In particular, the present disclosure provides compositions and methods for detecting the presence or absence of one or more types of gynecological cancer (e.g., cervical cancer, ovarian cancer, endometrial cancer) in a biological sample from a subject having or suspected of having a gynecological cancer.

Abstract: Provided herein is technology for cervical cancer screening. In particular, provided herein are methods, compositions, and related uses for detecting the presence or absence of cervical cancer, cervical pre-cancers (e.g., cervix related in-situ adenocarcinoma, cervical intraepithelial neoplasia), and cervical cancer subtypes (e.g., cervical adenocarcinoma, squamous cell cervical cancer), or for discriminating cervical cancer from other types of gynecological cancers (e.g., endometrial, and ovarian cancers) from a biological sample (e.g., a tissue sample (e.g., cervical tissue), a blood sample, a plasma sample, a serum sample, a whole blood sample, a secretion sample (e.g., cervical secretion, vaginal secretion), an organ secretion sample, a CSF sample, a saliva sample, a urine sample, or a stool sample).

Abstract: Provided herein is technology relating to detecting neoplasia and particularly, but not exclusively, to methods, compositions, and related uses for detecting premalignant and malignant neoplasms such as gastric cancer.

Abstract: Provided herein is technology for prostate cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of prostate cancer.

Abstract: Provided herein is technology relating to detecting neoplasia and particularly, but not exclusively, to methods, compositions, and related uses for detecting premalignant and malignant neoplasms such as pancreatic and colorectal cancer.

Abstract: Provided herein is technology for cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of non-Hodgkin lymphoma (NHL) and NHL subtypes (e.g., diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, peripheral T-cell lymphoma).

Abstract: This document relates to methods and materials for detecting premalignant and malignant neoplasms. For example, methods and materials for determining whether or not a stool sample from a mammal contains nucleic acid markers or polypeptide markers of a neoplasm are provided.

Abstract: Provided herein is technology for ovarian cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of ovarian cancer and sub-types of ovarian cancer (e.g., clear cell ovarian cancer, endometrioid ovarian cancer, mucinous ovarian cancer, serous ovarian cancer).

Abstract: Provided herein is technology for prostate cancer screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of prostate cancer.

Abstract: Provided herein is technology for colorectal neoplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of colorectal neoplasia in 1) individuals at, older or younger than 50 years of age, or 2) individuals having Lynch Syndrome.

Abstract: The invention relates to cell sampling devices. In particular, the present invention relates to ingestible cell sampling devices for sampling cells in a subject, and methods of use for detecting abnormalities in a subject using the same.

Abstract: Provided herein is technology for pancreatic neuroendocrine tumor screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of pancreatic neuroendocrine tumors.

Abstract: Provided herein is technology for primary cutaneous melanoma screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of primary cutaneous melanoma.

Abstract: Methods and systems for Vserver migration are provided. One method includes maintaining a state of a migrate operation for migrating a plurality of source storage volumes managed by a source storage virtual machine (Vserver) of a source cluster to a plurality of destination storage volumes of a destination cluster of a networked storage environment; restarting a process at a healthy node of the source cluster or the destination cluster to continue the migrate operation, in response to detecting an unhealthy node at the source cluster or the destination cluster executing the process; retrying a task associated with the migrate operation experiencing intermittent failure for a certain number of times, and upon successful execution, continuing the migration operation; and checking the state of the migrate operation and in response to the state of the migrate operation, continuing the migrate operation or restarting the migration operation.

Abstract: Methods and systems for Vserver migration are provided. One method includes executing a transfer phase of a migrate operation for migrating a Vserver of a source cluster to a destination cluster, using asynchronous baseline transfer to transfer a plurality of source storage volumes configured in a consistency group (CG) for the migrate operation to a plurality of destination storage volumes of a destination cluster; updating a state of each of the plurality of source storage volumes to a sync state indicating completion of a pre-commit phase of the migrate operation to initiate a commit phase of the migrate operation; and generating a snapshot of the plurality of destination storage volumes for performing data integrity checks between data stored at the source cluster and migrated data at destination cluster, after completing a commit phase of the migrate operation.

Abstract: Methods and systems for Vserver migration are provided. Update after claims are finalized. One method includes generating a consistency group (CG) having a plurality of source storage volumes of a source storage virtual machine (Vserver) of a source cluster for a migrate operation to migrate the source storage volumes as a group to a plurality of destination storage volumes of a destination cluster; establishing a mirroring relationship between the source and destination cluster for managing asynchronous transfer of the source storage volumes in the CG to the destination storage volumes during a transfer phase of the migrate operation; replicating a logical interface of the source cluster to the destination cluster, the logical interface providing a network address to access the source cluster; and automatically selecting a destination port at the destination cluster, associated with the replicated logical interface.

Abstract: Provided herein is technology for gastrointestinal neoplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of gastrointestinal neoplasm, and classifying the site location of such a gastrointestinal neoplasm (e.g., a colorectal region, a pancreaticobiliary region, a gastroesophageal region).

Abstract: Provided herein is technology for colorectal neoplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of colorectal neoplasia in 1) individuals at, older or younger than 50 years of age, or 2) individuals having Lynch Syndrome.